• 1
    Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Giffin SL. 2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila). 2009; 47:9111084.
  • 2
    Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002; 347:34756.
  • 3
    Protherics Inc. CroFab Prescribing Information. Brentwood, TN: Protherics Inc., 2006.
  • 4
    Offerman SR, Barry JD, Schneir A, Clark RF. Biphasic rattlesnake venom-induced thrombocytopenia. J Emerg Med. 2003; 24:28993.
  • 5
    Camilleri C, Offerman S, Gosselin R, Albertson T. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation. Clin Toxicol (Phila). 2005; 43:2016.
  • 6
    Gold BS, Barish RA, Rudman MS. Refractory thrombocytopenia despite treatment for rattlesnake envenomation. N Engl J Med. 2004; 350:19123.
  • 7
    Fazelat J, Teperman SH, Touger M. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine). Clin Toxicol (Phila). 2008; 46:8236.
  • 8
    Odeleye AA, Presley AE, Passwater ME, Mintz PD. Report of two cases: rattlesnake venom-induced thrombocytopenia. Ann Clin Lab Sci. 2004; 34:46770.
  • 9
    Richardson WH, Goto CS, Gutglass DJ, Williams SR, Clark RF. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom. Clin Toxicol (Phila). 2007; 45:4725.
  • 10
    Dart RC, Hurlbut KM, Garcia R, Boren J. Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996; 27:3216.
  • 11
    Seifert SA, Boyer LV, Benson BE, Rogers JJ. AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005. Clin Toxicol (Phila). 2009; 47:32735.
  • 12
    Boyer LV, Seifert SA, Clark RF, et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med. 1999; 159:70610.
  • 13
    O’Brien NF, DeMott MC, Suchard JR, Clark RF, Peterson BM. Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation. Pediatr Emerg Care. 2009; 25:4579.
  • 14
    Kitchens C, Eskin T. Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol. 2008; 4:1803.
  • 15
    Bond RG, Burkhart KK. Thrombocytopenia following timber rattlesnake envenomation. Ann Emerg Med. 1997; 30:404.
  • 16
    Schmaier AH, Claypool W, Colman RW. Crotalocytin: recognition and purification of a timber rattlesnake platelet aggregating protein. Blood. 1980; 56:10139.
  • 17
    Schmaier AH, Colman RW. Crotalocytin: characterization of the timber rattlesnake platelet activating protein. Blood. 1980; 56:10208.
  • 18
    Consroe P, Egen NB, Russell FE, et al. Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg. 1995; 53:50710.
  • 19
    Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002; 40:61924.
  • 20
    Isbister GK. Antivenom efficacy or effectiveness: the Australian experience. Toxicology. 2009; 268:14854.
  • 21
    Chippaux JP, Williams V, White J. Snake venom variability: methods of study, results and interpretation. Toxicon. 1991; 29:1279303.